This study aims to analyze the existence of information about deprescription in the leaflets of proton pump inhibitor (PPI) medications. The leaflets available on the Brazilian Health Regulatory ...

Objective To determine whether proton pump inhibitors (PPIs) are associated with an increased ... are needed to better inform the safety profile of this widely prescribed drug class. Thus, the ...

Use of proton pump inhibitors appears to increase the risk for kidney failure among patients with CKD. Use of proton pump inhibitors (PPIs) may spur progression to kidney failure in patients with ...

Proton-pump inhibitors (PPIs) are the most effective ... Of note, omeprazole — the only category C drug (i.e., animal studies have shown risk to a fetus) — was associated with the lowest ...

Objectives The widespread use of proton pump inhibitors (PPIs) raised concerns on the safety of long-term use of these drugs. Community pharmacists have great responsibility of educating patients on ...

Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, ...

Expert Rev Clin Pharmacol. 2013;6(4):443-451.

Unconventional Computing Laboratory, University of the West of England, Bristol BS16 1QY, U.K.